Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL–Negative Myeloproliferative Neoplasms

INTRODUCTION: The identification of specific molecular signatures and the development of new targeted drugs have changed the paradigm of onco-nephrology, now allowing a multiscale approach of kidney involvement related to hematologic malignancies relying on combined hematologic and molecular assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Belliere, Julie, Colombat, Magali, Kounde, Clément, Recher, Christian, Ribes, David, Huart, Antoine, Chauveau, Dominique, Demas, Véronique, Luquet, Isabelle, Beyne-Rauzy, Odile, Tavitian, Suzanne, Faguer, Stanislas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938079/
https://www.ncbi.nlm.nih.gov/pubmed/33732988
http://dx.doi.org/10.1016/j.ekir.2020.12.005